DK175178B1 - Indretning til styret afgivelse af et eller flere aktive stoffer til et brugsmiljö og fremgangsmåde til fremstilling deraf - Google Patents

Indretning til styret afgivelse af et eller flere aktive stoffer til et brugsmiljö og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK175178B1
DK175178B1 DK198904244A DK424489A DK175178B1 DK 175178 B1 DK175178 B1 DK 175178B1 DK 198904244 A DK198904244 A DK 198904244A DK 424489 A DK424489 A DK 424489A DK 175178 B1 DK175178 B1 DK 175178B1
Authority
DK
Denmark
Prior art keywords
weight
capsule
membrane
asymmetric
coating
Prior art date
Application number
DK198904244A
Other languages
Danish (da)
English (en)
Other versions
DK424489D0 (da
DK424489A (da
Inventor
John Robert Cardinal
Richard Wilker Korsmeyer
Scott Max Herbig
Jeelin Lo
Kelly Lincoln Smith
Avinash Govind Thombre
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK424489D0 publication Critical patent/DK424489D0/da
Publication of DK424489A publication Critical patent/DK424489A/da
Application granted granted Critical
Publication of DK175178B1 publication Critical patent/DK175178B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Executing Machine-Instructions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
DK198904244A 1988-08-30 1989-08-29 Indretning til styret afgivelse af et eller flere aktive stoffer til et brugsmiljö og fremgangsmåde til fremstilling deraf DK175178B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30
US23837188 1988-08-30

Publications (3)

Publication Number Publication Date
DK424489D0 DK424489D0 (da) 1989-08-29
DK424489A DK424489A (da) 1990-03-01
DK175178B1 true DK175178B1 (da) 2004-06-28

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198904244A DK175178B1 (da) 1988-08-30 1989-08-29 Indretning til styret afgivelse af et eller flere aktive stoffer til et brugsmiljö og fremgangsmåde til fremstilling deraf

Country Status (26)

Country Link
EP (1) EP0357369B1 (no)
JP (1) JPH07112971B2 (no)
KR (1) KR920008701B1 (no)
CN (2) CN1058387C (no)
AT (1) ATE89162T1 (no)
AU (1) AU615104B2 (no)
CA (1) CA1338552C (no)
CZ (1) CZ277763B6 (no)
DD (1) DD289466A5 (no)
DE (1) DE68906488T2 (no)
DK (1) DK175178B1 (no)
EG (1) EG19189A (no)
ES (1) ES2041006T3 (no)
FI (1) FI102515B1 (no)
HU (1) HU222245B1 (no)
IE (1) IE62859B1 (no)
IL (1) IL91398A (no)
MX (1) MX173942B (no)
MY (1) MY104183A (no)
NO (1) NO179232C (no)
NZ (1) NZ230470A (no)
PL (1) PL163079B1 (no)
PT (1) PT91560B (no)
RU (2) RU1837873C (no)
YU (1) YU47422B (no)
ZA (1) ZA896586B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
EP0550641B1 (en) * 1990-09-28 1994-05-25 Pfizer Inc. Dispensing device containing a hydrophobic medium
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
TW235239B (no) * 1992-11-20 1994-12-01 Pfizer
WO1994012159A1 (en) * 1992-11-30 1994-06-09 Pfizer Inc. Supported liquid membrane delivery devices
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CN1475208A (zh) * 1997-07-01 2004-02-18 �Ʒ� 舍曲林的缓释剂型
KR100446366B1 (ko) * 1997-07-01 2004-09-01 화이자 인코포레이티드 서트랄린 염 및 서트랄린의 서방성 투여형
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
EP1813273A1 (en) * 1998-11-12 2007-08-01 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
WO2000069418A1 (en) * 1999-05-17 2000-11-23 The Dow Chemical Company Process for making cellulose ether capsules with organic acids
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
CA2481025A1 (en) 2002-04-04 2003-10-16 Tanya Havlir Palatable chewable tablet
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
AU2005299490C1 (en) 2004-10-21 2012-01-19 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2009500339A (ja) * 2005-06-29 2009-01-08 アルザ・コーポレーシヨン 浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
CA2631233C (en) 2005-11-28 2011-11-08 Marinus Pharmaceuticals Ganaxolone formulations and methods for the making and use thereof
EP2248541B1 (de) * 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
WO2021094953A1 (en) 2019-11-14 2021-05-20 Pfizer Inc. 1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
JP2023517346A (ja) 2020-02-03 2023-04-25 ジョンソン アンド ジョンソン コンシューマー インコーポレイテッド セチリジンを含む単層チュアブル錠剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (no) * 1960-11-29
DE3167521D1 (en) * 1981-01-22 1985-01-17 Capsugel Ag A process for producing a pharmaceutical capsule having enteric properties
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
CA1239034A (en) * 1984-08-17 1988-07-12 Kelly L. Smith Delivery system
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
NO179232B (no) 1996-05-28
CN1058387C (zh) 2000-11-15
JPH02174713A (ja) 1990-07-06
PL163079B1 (pl) 1994-02-28
JPH07112971B2 (ja) 1995-12-06
HU222245B1 (hu) 2003-05-28
FI102515B (fi) 1998-12-31
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
RU1837873C (ru) 1993-08-30
DD289466A5 (de) 1991-05-02
FI102515B1 (fi) 1998-12-31
ES2041006T3 (es) 1993-11-01
NZ230470A (en) 1991-06-25
IL91398A0 (en) 1990-04-29
YU165789A (en) 1992-05-28
HUT74086A (en) 1996-11-28
KR920008701B1 (ko) 1992-10-08
PT91560A (pt) 1990-03-30
NO179232C (no) 1996-09-04
ATE89162T1 (de) 1993-05-15
CN1042072A (zh) 1990-05-16
IE62859B1 (en) 1995-03-08
DE68906488T2 (de) 1993-09-09
IE892771L (en) 1990-02-28
EP0357369A2 (en) 1990-03-07
EG19189A (en) 1994-11-30
NO893450L (no) 1990-03-01
ZA896586B (en) 1991-04-24
KR900002821A (ko) 1990-03-23
CA1338552C (en) 1996-08-27
AU4089189A (en) 1990-05-31
PT91560B (pt) 1995-05-04
DE68906488D1 (de) 1993-06-17
DK424489A (da) 1990-03-01
FI894046A0 (fi) 1989-08-29
CZ277763B6 (en) 1993-04-14
MY104183A (en) 1994-02-28
MX173942B (es) 1994-04-11
EP0357369A3 (en) 1991-10-02
CN1125573A (zh) 1996-07-03
RU2093147C1 (ru) 1997-10-20
EP0357369B1 (en) 1993-05-12
FI894046A (fi) 1990-03-01
YU47422B (sh) 1995-03-27
IL91398A (en) 1994-05-30
AU615104B2 (en) 1991-09-19
NO893450D0 (no) 1989-08-29

Similar Documents

Publication Publication Date Title
DK175178B1 (da) Indretning til styret afgivelse af et eller flere aktive stoffer til et brugsmiljö og fremgangsmåde til fremstilling deraf
US5612059A (en) Use of asymmetric membranes in delivery devices
BE1001101A5 (fr) Forme de dosage pour le traitement des maladies cardiovasculaires.
US5178868A (en) Dosage form
DE68907762T2 (de) Arzneizubereitung mit gesteuerter Wirkstofffreisetzung und Verfahren zu deren Herstellung.
DE69524214T3 (de) Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
CN101518517B (zh) 药物剂量逐渐增加的剂型
DE69320056T2 (de) Abgabevorrichtung mit eingekapselten hilfsmitteln
FR2545721A1 (fr) Dispositif osmotique pour la liberation de matieres dans un milieu d'utilisation
JPS61249917A (ja) 薬剤放出開始時期を制御する手段を備えた浸透圧利用薬剤投与具
PT98571B (pt) Dispositivos para a libertacao controlada que utilizam membranas polimerizadas interfacialmente e de processos para a sua preparacao
FR2554001A1 (fr) Capsule osmotique pour l'apport de substances actives a un milieu environnant
JPH0647529B2 (ja) 不活性なコア部を有する浸透圧利用薬剤投与具
JPS61185272A (ja) 脂質浸透ポンプ
CA2000932C (en) Oral pharmaceutical controlled release multiple unit dosage form
MXPA05000206A (es) Forma de dosificiacion oral que comprende una formulacion liquida de agente activo y liberacion controlada de la misma mediante una composicion osmotica expansible.
JP2007520421A (ja) 経口投与用放出制御型薬物送達システム
KR20050001734A (ko) 서방형 약물 전달 기구
DK175608B1 (da) Hidtil ukendt doseringsform

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK